These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21264224)

  • 1. Density of healthcare providers and patient outcomes: evidence from a nationally representative multi-site HIV treatment program in Uganda.
    Bakanda C; Birungi J; Mwesigwa R; Zhang W; Hagopian A; Ford N; Mills EJ
    PLoS One; 2011 Jan; 6(1):e16279. PubMed ID: 21264224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda.
    Bakanda C; Birungi J; Mwesigwa R; Nachega JB; Chan K; Palmer A; Ford N; Mills EJ
    PLoS One; 2011 Apr; 6(4):e19261. PubMed ID: 21559441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.
    Kiboneka A; Wangisi J; Nabiryo C; Tembe J; Kusemererwa S; Olupot-Olupot P; Joffres M; Anema A; Cooper CL; Montaner JS; Mills EJ
    AIDS; 2008 Nov; 22(18):2493-9. PubMed ID: 19005272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Hogg RS; Ford N; Nachega JB; Cooper CL
    J Int AIDS Soc; 2011 Nov; 14():52. PubMed ID: 22050673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human resources requirements for highly active antiretroviral therapy scale-up in Malawi.
    Muula AS; Chipeta J; Siziya S; Rudatsikira E; Mataya RH; Kataika E
    BMC Health Serv Res; 2007 Dec; 7():208. PubMed ID: 18093318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.
    Abaasa AM; Todd J; Ekoru K; Kalyango JN; Levin J; Odeke E; Karamagi CA
    BMC Health Serv Res; 2008 Nov; 8():241. PubMed ID: 19021908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perceived determinants and recommendations by mothers and healthcare professionals on the loss-to-follow-up in Option B+ program and child mortality in the Amhara region, Ethiopia.
    Kassaw MW; Matula ST; Abebe AM; Kassie AM; Abate BB
    BMC Infect Dis; 2020 Nov; 20(1):876. PubMed ID: 33228559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "I Always Worry about What Might Happen Ahead": Implementing Safer Conception Services in the Current Environment of Reproductive Counseling for HIV-Affected Men and Women in Uganda.
    Matthews LT; Bajunirwe F; Kastner J; Sanyu N; Akatukwasa C; Ng C; Rifkin R; Milford C; Moore L; Wilson IB; Bangsberg DR; Smit JA; Kaida A
    Biomed Res Int; 2016; 2016():4195762. PubMed ID: 27051664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic support reduces nonretention in a comprehensive, community-based antiretroviral therapy program in Uganda.
    Talisuna-Alamo S; Colebunders R; Ouma J; Sunday P; Ekoru K; Laga M; Wagner G; Wabwire-Mangen F
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):e52-9. PubMed ID: 22217680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial stewardship: Attitudes and practices of healthcare providers in selected health facilities in Uganda.
    Kimbowa IM; Eriksen J; Nakafeero M; Obua C; Lundborg CS; Kalyango J; Ocan M
    PLoS One; 2022; 17(2):e0262993. PubMed ID: 35113932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
    Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
    Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: risk factors and the fate of these patients.
    Saka B; Landoh DE; Patassi A; d'Almeida S; Singo A; Gessner BD; Pitché PV
    Pan Afr Med J; 2013; 15():35. PubMed ID: 24009811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does social support in addition to ART make a difference? Comparison of households with TASO and MOH PLWHA in Central Uganda.
    Abimanyi-Ochom J; Lorgelly P; Hollingsworth B; Inder B
    AIDS Care; 2013; 25(5):619-26. PubMed ID: 23062016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda.
    Moore DM; Yiannoutsos CT; Musick BS; Tappero J; Degerman R; Campbell J; Were W; Kaharuza F; Alexander LN; Downing R; Mermin J
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):289-96. PubMed ID: 21857358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV-Brazil cohort study: design, methods and participant characteristics.
    Grangeiro A; Escuder MM; Cassenote AJ; Souza RA; Kalichman AO; Veloso VG; Ikeda ML; Barcellos NT; Brites C; Tupinanbás U; Lucena NO; da Silva CL; Lacerda HR; Grinsztejn B; Castilho EA
    PLoS One; 2014; 9(5):e95673. PubMed ID: 24789106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient satisfaction among persons living with HIV/AIDS and receiving antiretroviral therapy in urban Uganda: A factor analysis.
    Sekandi JN; Castellanos ME; Woldu H; Kakaire R; Mutembo S; Mutanga JN
    PLoS One; 2023; 18(2):e0280732. PubMed ID: 36730252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.